Incidence of and survival after surgery for metastatic spine disease: a nationwide register-based study between 1997 and 2020 from Finland
DOI:
https://doi.org/10.2340/17453674.2025.43264Keywords:
Metastatic bone diseas, Oncology, SpineAbstract
Background and purpose: Information on metastatic spine disease (MSD) based on nationwide data on trends and postoperative survival is limited but is needed to optimize treatment in this population. We aimed to assess the incidence of and survival rates after MSD surgery.
Methods: This retrospective nationwide register-based study combined data from the Finnish Cancer Registry, Finnish Care Register for Health Care, and the Finnish Cause of Death Register from 1997 to 2020. Surgeries were identified using diagnosis and procedural codes, with primary spine pathologies excluded. Incidence rates were calculated per 100,000 inhabitants and adjusted for age and sex. Survival analysis was conducted using the Kaplan–Meier estimator.
Results: 1,845 patients underwent 1,992 surgeries, with a mean age of 65 years; 58% were men. The most common primary cancers were prostate cancer (15.1%), breast cancer (11.6%), and myeloma (10.6%). The incidence of MSD surgery increased by 87%, from 1.05 to 1.97 per 100,000 person-years. Surgery increased most among patients aged 70–79 years. Over the same period, the 6-month survival remained fairly stable. The overall survival probabilities were 57% (95% confidence interval [CI] 54–59) at 1 year, 44% (CI 42–46) at 2 years, 28% (CI 26–30) at 5 years, and 18% (CI 16–20) at 10 years. The 1-year survival was highest in patients with breast cancer at 75% (CI 69–81) and lowest in patients with kidney cancer at 45% (CI 38–53) and prostate cancer at 47% (CI 42–53).
Conclusion: Finnish nationwide data showed an increase in MSD surgery between 1997 and 2020 with a stable postoperative survival of 57% (CI 48–69) to 76% (CI 66–89) at 6 months.
Downloads
References
Smith B D, Smith G L, Hurria A, Hortobagyi G N, Buchholz T A. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 2009; 27(17): 2758-65. doi: 10.1200/JCO.2008.20.8983. DOI: https://doi.org/10.1200/JCO.2008.20.8983
Santucci C, Carioli G, Bertuccio P, Malvezzi M, Pastorino U, Boffetta P, et al. Progress in cancer mortality, incidence, and survival: a global overview. Eur J Cancer Prev 2020; 29(5): 367-81. doi: 10.1097/CEJ.0000000000000594. DOI: https://doi.org/10.1097/CEJ.0000000000000594
Van den Brande R, Cornips E M, Peeters M, Ost P, Billiet C, Van de Kelft E. Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: a systematic review. J Bone Oncol 2022; 35: 100446. doi: 10.1016/j.jbo.2022.100446. DOI: https://doi.org/10.1016/j.jbo.2022.100446
Patchell R A, Tibbs P A, Regine W F, Payne R, Saris S, Kryscio R J, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005; 366(9486): 643-8. doi: 10.1016/S0140-6736(05)66954-1. DOI: https://doi.org/10.1016/S0140-6736(05)66954-1
Barzilai O, Bilsky M H, Laufer I. The role of minimal access surgery in the treatment of spinal metastatic tumors. Global Spine J 2020; 10(2 Suppl): 79S-87S. doi: 10.1177/2192568219895265. DOI: https://doi.org/10.1177/2192568219895265
Amelot A, Balabaud L, Choi D, Fox Z, Crockard H A, Albert T, et al. Surgery for metastatic spine tumors in the elderly: advanced age is not a contraindication to surgery! Spine J 2017; 17(6): 759-67. doi: 10.1016/j.spinee.2015.07.440. DOI: https://doi.org/10.1016/j.spinee.2015.07.440
Wright E, Ricciardi F, Arts M, Buchowski J M, Chung C K, Coppes M, et al. Metastatic spine tumor epidemiology: comparison of trends in surgery across two decades and three continents. World Neurosurg 2018; 114:e809-e17. doi: 10.1016/j.wneu.2018.03.091. DOI: https://doi.org/10.1016/j.wneu.2018.03.091
Carrwik C, Olerud C, Robinson Y. Survival after surgery for spinal metastatic disease: a nationwide multiregistry cohort study. BMJ Open 2021; 11(11): e049198. doi: 10.1136/bmjopen-2021-049198. DOI: https://doi.org/10.1136/bmjopen-2021-049198
Bhanot K, Widdifield J, Huang A, Paterson J M, Shultz D B, Finkelstein J. Survival after surgery for spinal metastases: a population-based study. Can J Surg 2022; 65(4): E512-E8. doi: 10.1503/cjs.000921. DOI: https://doi.org/10.1503/cjs.000921
Pennington Z, Porras J L, Larry Lo S F, Sciubba D M. International variability in spinal metastasis treatment: a survey of the AO Spine community. Global Spine J 2023; 13(6): 1622-34. doi: 10.1177/21925682211046904. DOI: https://doi.org/10.1177/21925682211046904
Leinonen M K, Miettinen J, Heikkinen S, Pitkäniemi J, Malila N. Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours. Eur J Cancer 2017; 77: 31-9. doi: 10.1016/j.ejca.2017.02.017. DOI: https://doi.org/10.1016/j.ejca.2017.02.017
Sund R. Quality of the Finnish Hospital Discharge Register: a systematic review. Scand J Public Health 2012; 40(6): 505-15. doi: 10.1177/1403494812456637. DOI: https://doi.org/10.1177/1403494812456637
Huttunen T T, Kannus P, Pihlajamaki H, Mattila V M. Pertrochanteric fracture of the femur in the Finnish National Hospital Discharge Register: validity of procedural coding, external cause for injury and diagnosis. BMC Musculoskelet Disord 2014; 15: 98. doi: 10.1186/1471-2474-15-98. DOI: https://doi.org/10.1186/1471-2474-15-98
Park S J, Park J S, Lee C S, Kang B J, Jung C W. Trends in survival and surgical methods in patients surgically treated for metastatic spinal tumors: 25-year experience in a single institution. Clin Orthop Surg 2023; 15(1): 109-17. doi: 10.4055/cios22115. DOI: https://doi.org/10.4055/cios22115
Wagner A, Haag E, Joerger A K, Jost P, Combs S E, Wostrack M, et al. Comprehensive surgical treatment strategy for spinal metastases. Sci Rep 2021; 11(1): 7988. doi: 10.1038/s41598-021-87121-1. DOI: https://doi.org/10.1038/s41598-021-87121-1
Pennington Z, Pairojboriboon S, Chen X, Sacino A, Elsamadicy A A, de la Garza Ramos R, et al. Utility of expanded anterior column resection versus decompression-alone for local control in the management of carcinomatous vertebral column metastases undergoing adjuvant stereotactic radiotherapy. Spine J 2022; 22(5): 835-46. doi: 10.1016/j.spinee.2021.10.016. DOI: https://doi.org/10.1016/j.spinee.2021.10.016
Glicksman R M, Tjong M C, Neves-Junior W F P, Spratt D E, Chua K L M, Mansouri A, et al. Stereotactic ablative radiotherapy for the management of spinal metastases: a review. JAMA Oncol 2020; 6(4): 567-77. doi: 10.1001/jamaoncol.2019.5351. DOI: https://doi.org/10.1001/jamaoncol.2019.5351
Verlaan J J, Choi D, Versteeg A, Albert T, Arts M, Balabaud L, et al. Characteristics of patients who survived < 3 months or > 2 years after surgery for spinal metastases: can we avoid inappropriate patient selection? J Clin Oncol 2016; 34(25): 3054-61. doi: 10.1200/JCO.2015.65.1497. DOI: https://doi.org/10.1200/JCO.2015.65.1497
Cardenas L M, Sigurdson S, Wallis C J D, Lalani A K, Swaminath A. Advances in the management of renal cell carcinoma. CMAJ 2024; 196(7): E235-E40. doi: 10.1503/cmaj.230356. DOI: https://doi.org/10.1503/cmaj.230356
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Leevi A Toivonen, Ville Ponkilainen, Jussi P Repo, Ville M Mattila
This work is licensed under a Creative Commons Attribution 4.0 International License.
